Recursos de colección

ORBi Open Repository and Bibliography (273.094 recursos)

In may 2007, the ULg's Administrative Board (joined in June 2007 by the FUSAGx) decided to create an institutional repository and defined a strong institutional self-archiving policy to increase the visibility, accessibility and impact of the University's publications (Board's decision). This decision led to the official launch, in November 2008, of the ORBi platform including both the Academic Bibliography and the Institutional Repository of the Wallonia-Europe University Academy.

Human health sciences => Hematology

Mostrando recursos 1 - 20 de 1.025

  1. Xenogeneic graft-versus-host disease: Impact of Th17 cells.

    Delens, Loïc; SERVAIS, Sophie; Vrancken, Louise; Ehx, Grégory; Fransolet, Gilles; Hannon, Muriel; DUBOIS, Sophie; Daulne, Coline; BEGUIN, Yves; Baron, Frédéric

  2. Limited Impact of Imatinib in a Murine Model of Sclerodermatouc Chronic Graft-versus-Host Disease

    Belle, Ludovic(*); Fransolet, Gilles(*); Somja, Joan; BINSFELD, Marilène; Delvenne, Philippe; Drion, Pierre; Hannon, Muriel; BEGUIN, Yves; Ehx, Grégory; Baron, Frédéric
    Peer reviewed

  3. Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.

    SERVAIS, Sophie; DUMONTIER, Nicolas; BIARD, L.; SCHNEPF, N.; RESCHE-RIGON, M.; PEFFAULT DE LATOUR, Régis; SCIEUX, C.; ROBIN, Marie; MEUNIER, M.; XHAARD, Aliéner; SICRE DE FONTBRUNE, Flore; LE GOFF, Jérôme; SOCIE, Gérard; SIMON, F; MAZERON, Marie-Christine
    Peer reviewed

  4. Alterations of circulating lymphoid committed progenitor cellular metabolism after allogeneic stem cell transplantation in humans

    GLAUZY; PEFFAULT DE LATOUR; ANDRE-SCHMUTZ; LACHUER; SERVAIS, Sophie; SOCIE, Gérard; CLAVE, Emmanuel; TOUBERT, Antoine
    Peer reviewed

  5. Performance evaluation of the new point-of-care coagulation analyzer Xprecia stride for measuring INR in VKA-treated patients – comparison with local laboratory automated reference method

    PETERS, Pierre; LECUT, Christelle; BOSSU, Olivier; GOTHOT, André
    Peer reviewed

  6. Limited impact of imatinib in a murine model of sclerodermatous chronic graft-versus-host disease (scl-cGVHD)

    Fransolet, Gilles; Belle, Ludovic; SOMJA, Joan; DELVENNE, Philippe; Hannon, Muriel; Drion, Pierre; BINSFELD, Marilène; BEGUIN, Yves; Ehx, Grégory; Baron, Frédéric
    Peer reviewed

  7. Limited impact of imatinib in a murine model of sclerodermic chronic graft-versus-host disease

    Belle, Ludovic; Fransolet, Gilles; SOMJA, Joan; BINSFELD, Marilène; DELVENNE, Philippe; Drion, Pierre; Hannon, Muriel; BEGUIN, Yves; Ehx, Grégory; Baron, Frédéric
    Peer reviewed

  8. Thrombose veineuse rénale : un cas didactique

    Tribolet, Sophie; DRESSE, Marie-Françoise; Lombet, Jacques; RIGO, Vincent; PIELTAIN, Catherine; Kalenga, Masendu
    Peer reviewed

  9. Sang de cordon état des lieux et perspectives

    BAUDOUX, Etienne

  10. Immunomodulatory Effects of the Agaricus blazei Murrill-Based Mushroom Extract AndoSan in Patients with Multiple Myeloma Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation: A Randomized, Double Blinded Clinical Study

    Tangen, Jon-Magnus; Tierens, Anne; CAERS, Jo; BINSFELD, Marilène; Olstad, Ole Kristoffer; Troseid, Anne-Marie Siebke; Wang, Junbai; Tjonnfjord, Geir Erland; Hetland, Geir
    Peer reviewed

  11. Different and synergistic effect of 5-Azacytidine and Rapamycin on ex vivo expansion of natural human T Regulatory cells

    Conteduca, Giuseppina
    Natural T regulatory cells (Treg) are challenging to expand ex vivo, and this has severely hindered in vivo evaluation of their therapeutic potential. 5-Azacytidine (5-azaC) and Rapamycin (RAPA) are immunosuppressive drugs that promote selectively the expansion of CD4+CD25highFoxp3+ regulatory T cells.: We investigated whether 5-azaC and RAPA could be used together to promote the ex vivo expansion of Tregs purified from adult human peripheral blood.We found that 5-azaC helped maintain FOXP3 expression during the expansion process probably by promoting the conversion of T conventional (Tconv) in Treg, instead Rapa induces selectively apoptosis in Tconv cells and expansion in Treg. Addition...

  12. Different and synergistic effect of 5-Azacytidine and Rapamycin on ex vivo expansion of natural human T Regulatory cells

    Conteduca, Giuseppina
    Natural T regulatory cells (Treg) are challenging to expand ex vivo, and this has severely hindered in vivo evaluation of their therapeutic potential. 5-Azacytidine (5-azaC) and Rapamycin (RAPA) are immunosuppressive drugs that promote selectively the expansion of CD4+CD25highFoxp3+ regulatory T cells. We investigated whether 5-azaC and RAPA could be used together to promote the ex vivo expansion of Tregs purified from adult human peripheral blood. : We found that 5-azaC helped maintain FOXP3 expression during the expansion process probably by promoting the conversion of T conventional (Tconv) in Treg, instead Rapa induces selectively apoptosis in Tconv cells and expansion in Treg....

  13. 5-Azacytidine and Rapamycin: different and synergistic effect on ex vivo expansion of natural human T Regulatory cells

    Conteduca, Giuseppina
    BACKGROUND: Natural T regulatory cells (Treg) are challenging to expand ex vivo, and this has severely hindered in vivo evaluation of their therapeutic potential. 5-Azacytidine (5-azaC) and Rapamycin (RAPA) are immunosuppressive drugs that promote selectively the expansion of CD4+CD25highFoxp3+ regulatory T cells OBJECTIVE: We investigated whether 5-azaC and RAPA could be used together to promote the ex vivo expansion of Tregs purified from adult human peripheral blood. METHODS: CD4+CD25+ and CD4+CD25- T cells were isolated from PBMC of normal controls using Miltenyi beads and FACS ARIA sorting. These cells subsets were cultured in the presence of anti-CD3/CD28 antibodies and 200 IU/ml of...

  14. Recommandations pour la prevention et la prise en charge des hemorragies massives.

    TONGLET, Martin; LARBUISSON, Robert; GERARD, Christiane; Benoit, Yves; brusselmans, Koen; Deneys, Veronique; De Paep, Rudi; De Waele, Jan; Ickx, Brigitte; Lambermont, Micheline; Latinne, Dominique; Loix, Sebastien; Muylle, Ludo; Peerlinck, Katelijn; Selleslag, Dominik; Stockman, Willem; Szabo, Bertrand; Vanderlinden, Philippe; Zachee, Pierre; Hubner, Roland
    Avis 8831 du Conseil Superieur de la Sante (CSS)

  15. Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.

    Tsirigotis, P.; Byrne, M.; Schmid, C.; Baron, Frédéric; Ciceri, F.; Esteve, J.; Gorin, N. C.; Giebel, S.; Mohty, M.; Savani, B. N.; Nagler, A.
    Peer reviewed

  16. Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.

    Versluis, J.; In 't Hout, F. E. M.; Devillier, R.; van Putten, W. L. J.; Manz, M. G.; Vekemans, M.-C.; Legdeur, M.-C.; Passweg, J. R.; Maertens, J.; Kuball, J.; Biemond, B. J.; Valk, P. J. M.; van der Reijden, B. A.; Meloni, G.; Schouten, H. C.; Vellenga, E.; Pabst, T.; Willemze, R.; Lowenberg, B.; Ossenkoppele, G.; Baron, Frédéric; Huls, G.; Cornelissen, J. J.
    Peer reviewed

  17. Low dose clofarabine in combination with a standard remission induction in patients 18-60 years with previously untreated intermediate and bad risk acute myeloid leukemia or high risk myelodysplastic syndrome: combined Phase I/II results of the EORTC/GIMEMA AML-14A Trial.

    Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, Sebastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, Frédéric
    Peer reviewed

  18. The place of viscoelastic testing in clinical practice.

    Hans, Grégory; Besser, Martin W.
    Peer reviewed

  19. Contraception hormonale chez l'adolescente avec thrombophilie biologique

    Minon, Jean-Marc; Vasbien, Myriam; DRESSE, Marie-Françoise; Pintiaux, Axelle
    Venous thromboembolism among pill users is rare but is a serious complication. Women with inherited thrombophilia are at increased risk when taking combined oral contraceptives. It is also truth for the contraceptive patch and vaginal ring. Hence, the adolescents with a know biological thrombophilia should not take htis type of hormonal conraception. However, some of these thrombophilia should not preclude use of estrogen containing contraception. Actually, if thrombophilia testing can be justified in asymptomtic patient at high risk, it is sometimes performed as screening in adolescent before estrogen-containnig contraception use ( non recommended). In these situations and considering the venous...

  20. Prophylactic donor lymphocyte infusion in patients with high-risk acute myeloid leukemia: ready for prime time?

    Baron, Frédéric; Beguin, Yves
    Peer reviewed

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.